causal

Companies game trials within the rules

When the difference between a p-value of 0.49 and 0.51 is $10 billion in expected revenue, companies will do everything legally permitted to win: choose the weakest comparator drug, run trials in settings with no further therapy after progression to exaggerate differences, enroll younger healthier populations, and skew dose-reduction rules to penalize the competitor—so as long as something is not explicitly prohibited, the incentive guarantees the thumb goes on the scale.

causalpending

Speaker

Vinay Prasad

Evidence Quote

“there's so many ways in which you can kind of put a thumb on the scale of a clinical trial. And, companies will do so as long as it's not explicitly prohibited.”

Source

Vinay Prasad on Cancer Drugs, Medical Ethics, and Malignant— EconTalk
Created: 6/13/2026, 12:28:36 AM

Your notes

Loading notes...